• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

weight loss

Hims  Hers Super Bowl commercial
Health Tech

Hims & Hers eyes $6.5B revenue target by 2030

The online health and wellness company's quarterly profit soared to $50 million, up 4x compared to a profit of $11 million a year prior.
Heather Landi May 5, 2025 5:00pm
Wegovy

Novo Nordisk taps Hims & Hers, LifeMD and Ro for GLP-1 tie-up

Apr 29, 2025 5:15pm
Two packages of a fictitious Semaglutide drug used for weight loss

Knownwell joins Lilly Direct; Hims & Hers adds weight loss meds

Apr 3, 2025 11:30am
Two injectable medications with a tape measure wrapped around them

Eli Lilly to offer low-cost GLP-1s with Teladoc, LifeMD

Mar 7, 2025 3:00pm
Two injectable medications with a tape measure wrapped around them

Industry Voices—The GLP-1 status quo is no longer acceptable

Mar 7, 2025 8:47am
three smartphones with screenshots of Hims  Hers weight loss program

Hims & Hers shares fall 23% despite upbeat earnings

Feb 24, 2025 5:30pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings